Antitumor antibiotic which inhibits topoisomerase II. Induces single-strand scission in DNA in the presence of reducing agents.
Product Specification
| Alternative Name: | Lambdamycin |
| |
| Formula: | C32H32O14 |
| |
| MW: | 640.6 |
| |
| Source: | Isolated from Streptomyces chartreusis. |
| |
| CAS: | 6377-18-0 |
| |
| MI: | 14: 2045 |
| |
| RTECS: | FL7350000 |
| |
| Purity: | ≥98% (HPLC) |
| |
| Identity: | Determined by 1H-NMR. |
| |
| Appearance: | Yellow solid. |
| |
| Solubility: | Soluble in acetone; insoluble in water. |
| |
| Shipping: | Ambient |
| |
| Short Term Storage: | +4°C |
| |
| Long Term Storage: | +4°C |
| |
| Use/Stability: | Stable for at least 1 year after receipt when stored at +4°C. |
| |
| Handling: | After reconstitution protect from light at -20°C. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
Chartreusin, elsamicin A and related anti-cancer antibiotics: J. Portugal; Curr. Med. Chem. Anticancer Agents
3, 411 (2003), Review,
Abstract;
Biochemical characterisation of elsamicin and other coumarin-related antitumour agents as potent inhibitors of human topoisomerase II: A. Lorico & B.H. Long; Eur. J. Cancer
14, 1985 (1993),
Abstract;
Chartreusin, a glycosidic antitumour antibiotic from Streptomyces: J.A. Beisler; Prog. Med. Chem.
19, 247 (1982), (Review),
Abstract;
Chartreusin, a New Antibiotic Produced by Streptomyces chartreusis, a New Species: B. E. Leach, et al.; J. Am. Chem. Soc. 75, 4011 (1953),
